Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin +/- Gentamicin in S. Aureus Infective Endocarditis
NCT00638157Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- Feb 2009
- Primary completion
- Nov 2011
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in infective endocarditis (IE), sponsored by Merck & Co.. Started Feb 2009; status: terminated.
02
Drugs
daptomycin
03
Conditions
infective endocarditis (IE)
Beyond the preview
Go deeper on NCT00638157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638157.